Ligand Pharma (LGND) Reports Glaxo (GSK) Granted Breakthrough Designation by FDA for Promacta/Revolade
Tweet Send to a Friend
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) announced that the U.S. Food and Drug Administration (FDA) has granted its partner GlaxoSmithKline plc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
